Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amcinonide is a highly potent synthetic topical corticosteroid used to treat inflammation, redness, itching, and swelling associated with various dermatologic conditions such as atopic dermatitis and allergic contact dermatitis. It acts primarily as an agonist of the glucocorticoid receptor. The anti-inflammatory effects are thought to result from the induction of phospholipase A2 inhibitory proteins (lipocortins), which inhibit the release of arachidonic acid—a precursor for inflammatory mediators like prostaglandins and leukotrienes. Amcinonide is available by prescription in forms such as cream, ointment, and lotion (typically 0.1%). Its primary indication is for skin conditions responsive to corticosteroids[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Amcinonide.